Older adults with atrial fibrillation remain undertreated with oral anticoagulants — despite the availability of new and better drugs, investigators say.
Laundry practices often overlooked in infection control, accreditor says
By
Alicia Lasek
Sep 09, 2020
Laundry practices deserve a bigger role in COVID-19 prevention strategies for nursing homes and senior living communities, experts warn.
Medicare Advantage retaining sicker patients with more complex health needs: study
By
Alicia Lasek
Jun 29, 2023
After years of criticism for cherry-picking healthier people for enrollment, Medicare Advantage is now holding onto more patients with chronic conditions, investigators say.
Virtual EMR review may improve care delivery during resident transfers, nurses say
By
Alicia Lasek
Jun 21, 2023
With the correct supports in place, virtual review of transferred residents’ electronic medical records may help nursing home clinicians deliver continuity of care and effective interventions, LTC nurses...
New data: With no booster, nursing home residents face 30 percent higher COVID risk
By
Alicia Lasek
Jan 29, 2023
Nursing home residents who have received the COVID-19 bivalent booster shot are 30% to 50% less likely to become infected with SARS-CoV-2 than their fellow residents who haven’t gotten boosted, the...
WHO turns attention to fungal infections as drug resistance builds
By
Alicia Lasek
Oct 26, 2022
The World Health Organization has created a first-ever priority list of fungi that it says pose the greatest emerging threats to public health.
Federal ‘all or none’ sepsis policy a wash in multi-hospital study
By
Alicia Lasek
Apr 20, 2021
SEP-1 requirements meant to combat staggering sepsis rates in the U.S. did not lead to clinically meaningful patient outcomes in 11 UPMC hospitals, physician-scientists say.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...